Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Kristian Reich

Kristian Reich

Co-founder and Chief Scientific Officer, MoonLake Immunotherapeutics

Appears in 1 story

Stories

MoonLake pushes sonelokimab toward FDA approval for a painful skin disease

New Capabilities

Guiding the clinical case for sonelokimab

Hidradenitis suppurativa causes painful, recurring abscesses in the skin folds of about 1 in 100 people. For most of the past decade, one drug controlled it well enough to win U.S. approval.

Updated Jun 23